ID
42598
Descrizione
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the Significant Medical/ Surgical History And Physical Examination and the Prior Medication form. It has to be filled in for screening.
Keywords
versioni (4)
- 01-09-17 01-09-17 -
- 18-06-19 18-06-19 -
- 18-06-19 18-06-19 -
- 17-09-21 17-09-21 -
Titolare del copyright
GlaxoSmithKline
Caricato su
17 september 2021
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Significant Medical/ Surgical History And Physical Examination, Prior Medication
Descrizione
Significant Medical/ Surgical History And Physical Examination
Alias
- UMLS CUI-1
- C0262926
- UMLS CUI-2
- C0031809
Descrizione
If you tick Yes, fill in the follwoing items for each diagnosis. Only in the absence of a diagnosis, record the signs and symptoms on separate lines.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1699700
- UMLS CUI [2]
- C0543467
Descrizione
Diagnosis
Tipo di dati
text
Alias
- UMLS CUI [1]
- C0011900
Descrizione
Month Year
Tipo di dati
partialDate
Alias
- UMLS CUI [1,1]
- C0439234
- UMLS CUI [1,2]
- C0011900
Descrizione
Medical condition
Tipo di dati
text
Descrizione
Prior Medication
Alias
- UMLS CUI-1
- C2826257
Descrizione
If you tick ‘Yes’, please record each medication in the following items.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2826257
Descrizione
(Trade name preferred)
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2360065
Descrizione
(eg 500 mg)
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1960417
Descrizione
(eg BID, PRN)
Tipo di dati
text
Alias
- UMLS CUI [1]
- C3476109
Descrizione
Other routes may be entered onto the form when appropriate, and will be coded prior to data entry.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C0013153
Descrizione
Indication on Prior Medication page must correlate utilizing the same terminology. Indication on Concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Descrizione
(e.g. 6 years)
Tipo di dati
text
Alias
- UMLS CUI [1]
- C0444921
Descrizione
day month year. If therapy/medication is continuing tick the follwing item.
Tipo di dati
date
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [2,1]
- C0013227
- UMLS CUI [2,2]
- C0806020
Descrizione
If a medication was marked continuing at the initial visit (on the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1553904
Similar models
Significant Medical/ Surgical History And Physical Examination, Prior Medication
C0031809 (UMLS CUI-2)
C0543467 (UMLS CUI [2])
C0011900 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0806020 (UMLS CUI [2,2])
Non ci sono commenti